Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.
Molecular Weight:
704.91
Purity:
>99.99%
CAS Number:
[207844-01-7]
Formula:
C38H52CaN2O8
Target:
Potassium Channel
* VAT and and shipping costs not included. Errors and price changes excepted